Stock IdeasStrong Buy StocksStrong Buy Stocks from Top Wall Street AnalystsLatest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen
Stock IdeasStrong Buy Stocks
| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Zymeworks IncZYME | $27.20 | Strong Buy | $39.00 | +43.38% | 20 hours ago | |
Analyst RankingTop 6% #328 out of 5525 analysts Average Return+8.72% Win Rate46%162 out of 349 Risk vs RewardPoor Good Analyst ColorCitigroup's Yigal Nochomovitz raised their price target on Zymeworks (NASDAQ: ZYME) by 2.6% from $38 to $39 on 2026/09/29. The analyst maintained their Strong Buy rating on the stock. Nochomovitz said their price target hike was catalyzed by the close of the Theravance Biopharma acquisition because the deal provides financial visibility for Zymeworks. The analyst also cited management commentary that Yupelri remains underpenetrated across both hospital and community channels. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.